DE69916248D1 - D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind - Google Patents

D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind

Info

Publication number
DE69916248D1
DE69916248D1 DE69916248T DE69916248T DE69916248D1 DE 69916248 D1 DE69916248 D1 DE 69916248D1 DE 69916248 T DE69916248 T DE 69916248T DE 69916248 T DE69916248 T DE 69916248T DE 69916248 D1 DE69916248 D1 DE 69916248D1
Authority
DE
Germany
Prior art keywords
chiro
inositol
anovulation
hyperandrogenism
containing compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916248T
Other languages
English (en)
Inventor
Geoffrey Allan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insmed Pharmaceuticals Inc
Original Assignee
Insmed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insmed Pharmaceuticals Inc filed Critical Insmed Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69916248D1 publication Critical patent/DE69916248D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69916248T 1998-01-27 1999-01-21 D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind Expired - Lifetime DE69916248D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/014,398 US5906979A (en) 1998-01-27 1998-01-27 Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
PCT/US1999/001197 WO1999037309A1 (en) 1998-01-27 1999-01-21 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation

Publications (1)

Publication Number Publication Date
DE69916248D1 true DE69916248D1 (de) 2004-05-13

Family

ID=21765259

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916248T Expired - Lifetime DE69916248D1 (de) 1998-01-27 1999-01-21 D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind

Country Status (11)

Country Link
US (1) US5906979A (de)
EP (2) EP1052997B1 (de)
JP (1) JP2002501027A (de)
CN (1) CN1291894A (de)
AT (1) ATE263567T1 (de)
AU (1) AU748679B2 (de)
CA (1) CA2319199A1 (de)
DE (1) DE69916248D1 (de)
NO (1) NO20003805L (de)
TW (1) TW572756B (de)
WO (1) WO1999037309A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5277000A (en) 1999-05-20 2000-12-12 Humanetics Corporation Stimulating transport of glucose into animal tissue by the administration of pinitol
US6673352B1 (en) * 1999-09-14 2004-01-06 The General Hospital Corporation Use of Mullerian inhibiting substance for treating excess androgen states
KR20010091341A (ko) * 2000-03-14 2001-10-23 신용철 카이로이노시톨 추출물을 유효성분으로 함유하는 의약조성물
US20030212134A1 (en) * 2001-04-16 2003-11-13 Dykstra John C. Combination of pinitol and creatine to enhance uptake and retention of creatine
US20020193379A1 (en) * 2001-06-05 2002-12-19 Insmed Incorporated Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals
US20060068387A1 (en) * 2002-04-22 2006-03-30 Northwestern University Genetic marker for endocrine disorders
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040156923A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and nutraceutical composition for mammals
US20060004096A1 (en) * 2004-05-28 2006-01-05 Joseph Larner Method of Treating Endothelial Dysfunction, Oxidative Stress and Related Diseases
US20060258754A1 (en) * 2004-05-28 2006-11-16 Joseph Larner Method of treating endothelial dysfunction, oxidative stress and related diseases
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
JP5815728B2 (ja) * 2010-11-19 2015-11-17 ザ プロクター アンド ギャンブルカンパニー トリプシン活性を阻害又は低減するための化粧品組成物及び方法
ITFI20110241A1 (it) * 2011-11-03 2013-05-04 Lo Li Pharma Srl Formulazioni per migliorare la probabilità di fecondazione ed il numero di gravidanze
ITFI20110252A1 (it) * 2011-11-22 2013-05-23 Lo Li Pharma Srl Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
US9259410B2 (en) * 2014-04-08 2016-02-16 Oculus Innovative Sciences, Inc. Methods of treating polycystic ovarian syndrome using chlorogenic acid and inositol
CN109310598B (zh) 2016-04-27 2022-04-19 小林制药株式会社 育毛剂
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
BR112020010343A2 (pt) * 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
PL238919B1 (pl) 2018-02-28 2021-10-18 Verco Spolka Akcyjna Kompozycja farmaceutyczna zawierająca mio-inozytol i D-chiro- inozytol, do zastosowania w terapeutycznym sposobie obniżania masy ciała u kobiet z zespołem policystycznych jajników
KR102037879B1 (ko) * 2018-03-22 2019-10-29 주식회사 메타포뮬러 가임능 개선용 조성물 및 그 제조방법
KR102077992B1 (ko) * 2019-07-22 2020-02-17 뉴트리진 주식회사 가임능 개선용 조성물 및 그 제조방법
CN112316122B (zh) * 2020-11-02 2022-08-09 山东省大健康精准医疗产业技术研究院 一种治疗多囊卵巢综合征的组合物及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) * 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (ja) * 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) * 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
EP0142641B1 (de) * 1983-09-26 1991-01-16 Udo Dr. Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0143949B1 (de) * 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmazeutische Zusammensetzung mit Gehalt an Urokinase
US4801597A (en) * 1985-06-11 1989-01-31 University Of Florida Certain inositol-nicotinate ester derivatives and polyionic complexes therefore useful for treating diabetes meuitus, hyperlipidemia and lactic acidosis
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
EP0624092A1 (de) * 1992-01-28 1994-11-17 I.R.2.M. Verwendung von niobiumderivaten zur herstellung von arfneimitteln zur behandlung oder vorbehandlung von stoffwechselstörungen
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders

Also Published As

Publication number Publication date
WO1999037309A9 (en) 1999-10-07
EP1348438A1 (de) 2003-10-01
AU748679B2 (en) 2002-06-13
TW572756B (en) 2004-01-21
WO1999037309A1 (en) 1999-07-29
CN1291894A (zh) 2001-04-18
NO20003805D0 (no) 2000-07-25
CA2319199A1 (en) 1999-07-29
AU2329799A (en) 1999-08-09
EP1052997B1 (de) 2004-04-07
ATE263567T1 (de) 2004-04-15
NO20003805L (no) 2000-09-14
JP2002501027A (ja) 2002-01-15
US5906979A (en) 1999-05-25
EP1052997A1 (de) 2000-11-22

Similar Documents

Publication Publication Date Title
DE69916248D1 (de) D-chiro-inositol-enthaltende zusammensetzungen zur behandlung von metabolischen krankheiten, die durch hyperandrogenismund/oder anovulation gekennzeichnet sind
AR015487A1 (es) Uso de un compuesto de colesterol hidroxilado como agente reductor para preparar una composicion farmaceutica de utilidad en un metodo para inhibirla oxidacion de las lipoproteinas en un mamifero.
HK1091400A1 (en) Pharmaceutical compositions and methods for accelerating wound healing
DE60026152D1 (de) Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs
EP2221052A3 (de) Zusammensetzungen zur Modulation der Entzündungsreaktion
EA200800375A1 (ru) Соединения и способы ингибирования экспрессии vcam-1
IS2148B (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem COX-2 hindrar
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
WO2006026747A3 (en) Diphenylethylene compounds and uses thereof
WO2003009803A3 (en) Method of improving cognitive function
Akpolat et al. Protective effect of flaxseed oil on renal injury in hyperlipidaemic rats: the effect of flaxseed oil on hyperlipidaemia
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
ATE422886T1 (de) Neue heterocyclische analoge von diphenylethylenverbindungen
DE69916632D1 (de) Verwendung von zimtsäurederivaten zur herstellung eines medikamentes zur vorbeugung oder behandlung von erkrankungen die durch einen hohen blutfettspiegel bedingt sind
Al Batran et al. Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits
EA200501865A1 (ru) Аналоги тиовольфраматов и их применение
WO2006073456A3 (en) Anti-coronavirus compounds
WO2007044682A3 (en) Method for treating chronic pain
AU2003272189A1 (en) Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
ITRM990707A0 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni
HK1061355A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2001273964A1 (en) Fungicidal compositions
WO2003020218A3 (en) Salvianolic acid b

Legal Events

Date Code Title Description
8332 No legal effect for de